Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Comment by grosdavidon May 12, 2020 1:06pm

91 Views

Post# 31017707

RE:RE:RE:RE:RE:RE:RE:Here's your update on our Canadian trial, posted today!

Am I getting this wrong? Am I on AGN board? what do you think I'm all in one stock? I am diversified, I hold other stocks as well as AGN...hope you haven't put 100% of that 5K$ savings account you have on AGN.....

If you need personal advices, message me in private I will be glad to give you 1-2 tips :)

Please let me know who told me to get TF out of this board, I'm curious because I have a job and I can't read all the posts here.

Thanks Moose,
David

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages